Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer

Abstract Breast cancer (BC) is the most prevalent and highly heterogeneous malignancy affecting females worldwide, and its development is closely linked to metabolic reprogramming. In this study, label-free quantification (LFQ) was used to analyze the protein expression in exosomes secreted by BC dr...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxin Ji, Ruonan Li, Guohui Tang, Yuhan Xiao, Ruyin Ye, Jiwen Shi, Chenchen Geng, Ruorong Ran, Chengle Zhu, Wenrui Wang, Changjie Chen, Qingling Yang
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Cellular and Molecular Life Sciences
Subjects:
Online Access:https://doi.org/10.1007/s00018-025-05788-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849237692622045184
author Yuxin Ji
Ruonan Li
Guohui Tang
Yuhan Xiao
Ruyin Ye
Jiwen Shi
Chenchen Geng
Ruorong Ran
Chengle Zhu
Wenrui Wang
Changjie Chen
Qingling Yang
author_facet Yuxin Ji
Ruonan Li
Guohui Tang
Yuhan Xiao
Ruyin Ye
Jiwen Shi
Chenchen Geng
Ruorong Ran
Chengle Zhu
Wenrui Wang
Changjie Chen
Qingling Yang
author_sort Yuxin Ji
collection DOAJ
description Abstract Breast cancer (BC) is the most prevalent and highly heterogeneous malignancy affecting females worldwide, and its development is closely linked to metabolic reprogramming. In this study, label-free quantification (LFQ) was used to analyze the protein expression in exosomes secreted by BC drug-resistant cells, identifying RAS-associated binding protein (RAB) 10 as the most significantly upregulated protein. RAB10, a member of the small GTPase family with complex biological functions, is highly expressed in BC and is associated with poor prognosis. In this study, we mainly utilized mouse breast cancer 4T-1 cells (wild-type control cells) and tumor-induced 4T-1 cells (isolated from mouse in situ tumor tissues to simulate the phenotype of the in vivo tumor microenvironment), and on this basis, conducted in vitro functional verification and in vivo tumorigenesis experiments. A comprehensive multi-omics analysis, including metabolomics and proteomics, following RAB10 knockdown, demonstrated the crucial role of RAB10 in regulating central carbon metabolism, which is essential for autophagy and ferroptosis in BC cells. Our study further confirmed that RAB10 mediates metabolic reprogramming in BC cells by regulating the Slc37a2/mTOR pathway, leading to enhanced autophagy and inhibition of ferroptosis. This comprehensive multi-omics analysis elucidated the key molecular and regulatory mechanisms underlying RAB10-induced metabolic reprogramming in tumors, providing potential new therapeutic targets and biomarkers for prognostic assessment in BC treatment.
format Article
id doaj-art-68b12b8632694348963ffe0e4b0c2e5a
institution Kabale University
issn 1420-9071
language English
publishDate 2025-07-01
publisher Springer
record_format Article
series Cellular and Molecular Life Sciences
spelling doaj-art-68b12b8632694348963ffe0e4b0c2e5a2025-08-20T04:01:53ZengSpringerCellular and Molecular Life Sciences1420-90712025-07-0182112410.1007/s00018-025-05788-5Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancerYuxin Ji0Ruonan Li1Guohui Tang2Yuhan Xiao3Ruyin Ye4Jiwen Shi5Chenchen Geng6Ruorong Ran7Chengle Zhu8Wenrui Wang9Changjie Chen10Qingling Yang11Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityAnhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical UniversityDepartment of Life Sciences, Bengbu Medical UniversityDepartment of Biochemistry and Molecular Biology, Bengbu Medical UniversityDepartment of Biochemistry and Molecular Biology, Bengbu Medical UniversityAbstract Breast cancer (BC) is the most prevalent and highly heterogeneous malignancy affecting females worldwide, and its development is closely linked to metabolic reprogramming. In this study, label-free quantification (LFQ) was used to analyze the protein expression in exosomes secreted by BC drug-resistant cells, identifying RAS-associated binding protein (RAB) 10 as the most significantly upregulated protein. RAB10, a member of the small GTPase family with complex biological functions, is highly expressed in BC and is associated with poor prognosis. In this study, we mainly utilized mouse breast cancer 4T-1 cells (wild-type control cells) and tumor-induced 4T-1 cells (isolated from mouse in situ tumor tissues to simulate the phenotype of the in vivo tumor microenvironment), and on this basis, conducted in vitro functional verification and in vivo tumorigenesis experiments. A comprehensive multi-omics analysis, including metabolomics and proteomics, following RAB10 knockdown, demonstrated the crucial role of RAB10 in regulating central carbon metabolism, which is essential for autophagy and ferroptosis in BC cells. Our study further confirmed that RAB10 mediates metabolic reprogramming in BC cells by regulating the Slc37a2/mTOR pathway, leading to enhanced autophagy and inhibition of ferroptosis. This comprehensive multi-omics analysis elucidated the key molecular and regulatory mechanisms underlying RAB10-induced metabolic reprogramming in tumors, providing potential new therapeutic targets and biomarkers for prognostic assessment in BC treatment.https://doi.org/10.1007/s00018-025-05788-5Breast cancerRAB10MetabolismAutophagyFerroptosis
spellingShingle Yuxin Ji
Ruonan Li
Guohui Tang
Yuhan Xiao
Ruyin Ye
Jiwen Shi
Chenchen Geng
Ruorong Ran
Chengle Zhu
Wenrui Wang
Changjie Chen
Qingling Yang
Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer
Cellular and Molecular Life Sciences
Breast cancer
RAB10
Metabolism
Autophagy
Ferroptosis
title Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer
title_full Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer
title_fullStr Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer
title_full_unstemmed Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer
title_short Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer
title_sort integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by rab10 through slc37a2 mtor pathway in breast cancer
topic Breast cancer
RAB10
Metabolism
Autophagy
Ferroptosis
url https://doi.org/10.1007/s00018-025-05788-5
work_keys_str_mv AT yuxinji integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT ruonanli integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT guohuitang integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT yuhanxiao integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT ruyinye integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT jiwenshi integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT chenchengeng integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT ruorongran integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT chenglezhu integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT wenruiwang integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT changjiechen integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer
AT qinglingyang integrativeproteomicsandmetabolomicsanalysesrevealstheregulationofautophagyandferroptosisbyrab10throughslc37a2mtorpathwayinbreastcancer